(Q34098428)
Statements
1 reference
SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia (English)
1 reference
Hagop Kantarjian
1 reference
Arthur E Frankel
1 reference
Jorge Cortes
1 reference
Marina Konopleva
1 reference
Michael Andreeff
1 reference
Juliana Benito
1 reference
Borys Korchin
1 reference
Olga Frolova
1 reference
Chris Brooks
1 reference
Rui-Yu Wang
1 reference
Eric K Rowinsky
1 reference
19 June 2014
1 reference
1 reference
166
1 reference
862-874
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference